埃巴斯与低剂量抗抑郁药联合用于耐火性刺激性肠综合征:一项随机对照试验
Chao Wang1, Tengxiao Wang1, Yangfang Chen1
1Department of Gastroenterology, Affiliated Hospital of Jiaxing University, Zhejiang, China.
概括
将埃巴斯与抗抑郁药物结合使用,显著改善了耐火性刺激性肠综合征 (IBS) 症状和生活质量. 这种组合疗法还提高了IBS患者的心理状态,并降低了肠道透性.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 目前对耐火性刺激性肠综合征 (IBS) 的药物治疗提供了不令人满意的结果.
- 耐火性IBS患者经常表现出潜在的心理异常.
- 研究新的治疗策略对于管理耐火性IBS至关重要.
研究的目的:
- 评估EBASTIN与低剂量抗抑郁药物结合在治疗不耐药性IBS的临床疗效.
- 评估这种联合治疗对IBS症状,生活质量和心理状况的影响.
- 为了确定治疗对肠道透性标记物的影响.
主要方法:
- 一项随机对照试验,涉及105名耐性IBS患者.
- 患者被分配接受单独的埃巴斯 (A组) 或埃巴斯与弗鲁提克索和美利特拉 (B组) 合并治疗4周.
- 使用IBS-QOL,IBS-SSS和睡眠质量得分,以及血清D-乳酸盐 (D-LAC) 和I-FABP水平来评估肠道透性来测量有效性.
主要成果:
- 与A组和基线相比,B组在焦虑和抑郁的得分显著改善.
- 两组都在IBS-QOL,IBS-SSS和睡眠质量方面有所改善,但B组的影响更为明显.
- 在B组中,D-LAC和I-FABP的血清水平显著降低,这表明肠道透性得到改善.
结论:
- 耐火性IBS与心理异常和肠道透性的损害有关.
- 埃巴斯和抗抑郁药的组合为耐火性IBS患者提供了显著的好处,改善了生活质量,症状严重程度和睡眠质量.
- 这种组合疗法有效地解决了心理困扰,并增强了耐火性IBS的肠道屏障功能.
相关概念视频
01:17Drugs for Treatment of Diarrhea-Predominant IBS
117
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
117
01:21Drugs for Treatment of Constipation-Predominant IBS
109
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
109
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
173
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
173
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
113
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
113
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
93
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
93
01:17Irritable Bowel Syndrome I: Introduction
201
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
201